Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma

NCT02022761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Laninamivir octanoate

Sponsor

Biota Scientific Management Pty Ltd

Collaborators

[object Object]